Oxford Global

02/12/2022

📢 Research scientists at Stanford Medicine have identified plasmablasts — a gene signature recognised in blood cells that produce — as the strongest predictor of vaccine immunity.

The discovery provides a new and efficient way to measure the effectiveness of a vaccine to mitigate risks of .

As a predictive marker, this gene signature could be a game-changer for the industry and the future of vaccine development.

Find out more about the significance of the study, below 👇

Scientists at Stanford Medicine identify gene signature, plasmablasts, as the strongest predictor of vaccine immunity.

02/12/2022

📢 is a bacterial infection that can be spread from an infected tick to humans, affecting approximately 476,000 people in the US every year.

Whilst early diagnosis is usually easier to treat, the symptoms of the condition, such as tiredness, aches, and energy loss can sometimes last for years.

However, a new study released in Cell Reports Medicine has raised new hope for the early detection and treatment of the tick-borne illness.

Researchers from and have proposed that a specific set of genes activated in patients with long-term Lyme disease could be a potential .



Read all about it here 👇

Researchers have proposed that a specific set of genes activated in patients with long-term Lyme disease could act as a potential biomarker.

01/12/2022

📢Until now, it has been widely believed that lower levels of high-density lipoprotein (HDL) or ‘good’ is associated with an increased risk of heart attacks.

A new study analysing the cholesterol levels of black adults now challenges traditional perceptions of its role in predicting risk.

Supported by National Institutes of Health (NIH), the research shows that ‘good’ cholesterol levels are not an effective biomarker for cardiovascular disease among adult populations of different racial and ethnic groups.

The conclusions drawn indicate that common perceptions on the matter are derived from outdated data sets that lack .

Read more about the findings below 👇

A new study analysing cholesterol levels of black adults challenges traditional perceptions of its role in predicting heart disease risk.

23/11/2022

📢 Did you know that unique pathways present in could provide greater insight into distinct mechanisms of disease?

A new research study from Boston University's Chronic Traumatic Encephalopathy Center suggests neuroimmune proteins may serve as a diagnostic for certain .

To examine each tauopathy, the study used “a 71 immune-related protein multiplex ELISA panel…to analyse anterior cingulate grey matter from 127 individuals neuropathologically diagnosed with AD, CTE, PSP, CBD, and AGD.”

To read about the results, check-out our brand-new Industry Spotlight below 👇

Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.

15/11/2022

📢 Want to find out more about Oxford Global Conferences' upcoming Biomarkers for NASH Symposium?

Look no further 👀👇...

Discover key event highlights from Oxford Global's upcoming Biomarkers for NASH Symposium, happening on 07 December 2022,

07/11/2022

📢Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive .

The study published in PNAS Nexus showed that using the novel UBA-inhibiting drug TAK-243 could block the cellular function of UBA1 and kill cancer cells in mice with patient-derived breast tumours.

It is the first study to suggest that UBA1 inhibitors could be effective in .

Read all about it at on our content portal 📰 👇

Scientists at VCU Massey Cancer Center propose using the novel UBA-inhibiting drug TAK-243 to block UBA1 and kill cancer cells.

03/11/2022

📢 A study by The University of Edinburgh has pinpointed various genes reliably associated with .

Previously around one-third of the 42 genetic variants identified had been linked to educational attainment and cognitive abilities.

Published in Nature Genetics journal, the University’s latest findings provide compelling evidence and understanding of why some children struggle to read and spell.

A new study from the University of Edinburgh has identified potential gene indications associated with dyslexia.

20/10/2022

📢 Hot off the press ...

New research suggests acute exposure to elevates associated with skin diseases.

Researchers at the UC Riverside have found that acute exposure elevates biomarkers associated with .

Read all about it below 📰

New research suggests acute exposure to thirdhand smoke elevates biomarkers associated with skin diseases.

25/11/2021

With 2022 fast approaching, we are pleased to share details of our 2022 plans and activities. As always, connecting you with your key prospects, supporting your business development goals, and creating opportunities to promote your company is at the heart of what we do!

Our flagship events are returning in 2022, alongside some new additions to the event calendar based on current hot topics and fast-moving advancements in the industry. To further support lead-generation activities, alongside the in-person forums, there will be focused, single-day online symposiums and events, designed to connect you with prospective customers from around the globe.

Click here for a full list and dates of events in the Biologics Series, Biomarkers Series, Cell Series, Discovery Series, Formulation & Delivery Series, Immuno Series, NextGen Omic Series and PharmaTec Series: https://www.oxfordglobal.co.uk/calendar/

For further information on any of the above, a personalised proposal, or to arrange a call to discuss further, please e-mail [email protected]

31/10/2019

Say Hello to Oxford Global's New Websites!

With new menus and improved functionality, intuitive navigation on our sites has never been easier. Now fully responsive on mobile devices, you can have access to our latest news and content everywhere you go!

http://bit.ly/2JA1rTz

03/10/2019

We have teamed up with Cellenion to bring you a complimentary pre-congress webinar on optimising circulating tumour cells isolation for scRNA-Seq analyses.

Circulating tumour cells (CTCs) are shed by primary tumours into the bloodstream and form a key component of so-called liquid biopsies which have a significant role to play in tomorrow’s precision medicine.

Sign up and gain a stronger perspective. https://bit.ly/2n9zIkf

02/10/2019

Calling all genomics experts. Have you read our pre-event newsletter for SYNGENUK? It's our biggest newsletter to date, featuring exclusive insights from That's Good Science - Takara Bio USA.

It also has useful resources on creating genetically modified rodents with Charles River Labs and numerous case studies from leading industry experts - take a read today!

https://bit.ly/2obdy1e

27/09/2019

Browse through Q&A sessions with SynGen Series UK 2019 speakers and collaborators on areas such as Next Generation Sequencing, Precision Medicine & Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.

http://bit.ly/2n50fzb

26/09/2019

In November, we will host our eleventh SynGen Series UK event. We have built great relationships and partnerships over the years with academic and healthcare institutions, pharmaceutical companies and solution providers.

This year, we are proud to have the support and collaboration from cutting edge solution providers that are advancing the progress in genomics and life sciences.

26/09/2019

This year our key speakers include Jane Wilkinson from Broad Institute of MIT and Harvard, Lin Wu from Harvard University and Ed Schuuring from the University Medical Centre Gronningen.

We have a range of subject matter experts on the line up this year. Take a look at who will be speaking. https://bit.ly/2JlweAI

26/09/2019

Last year at our 10th Annual Next Generation Sequencing Congress, Mike Hubank, Head of Clinical Genomics at the Royal Marsden Hospital gave a great insight into genomics and clinical diagnostics.

Come out this year to hear about the improvements in the field a year later.

26/09/2019

Are you joining us for The SynGen Series UK this year? This event brings together Europe’s most successful genomics experts.

We are covering Next Generation Sequencing, Precision Medicine & Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.

Be a part of the conversation. https://bit.ly/2IxnA1T